In community-acquired pneumonia, adding oral clarithromycin to standard care increased early clinical response.
Ann Intern Med
; 177(5): JC51, 2024 May.
Article
em En
| MEDLINE
| ID: mdl-38710079
ABSTRACT
SOURCE CITATION Giamarellos-Bourboulis EJ, Siampanos A, Bolanou A, et al. Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS) a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2024;12294-304. 38184008.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Claritromicina
/
Infecções Comunitárias Adquiridas
/
Antibacterianos
Limite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Ann Intern Med
Ano de publicação:
2024
Tipo de documento:
Article